 | • レポートコード：B-GIR09D4091 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、長時間作用性インスリンの世界市場について調べ、まとめました。種類別セグメントは、インスリングラルギン、インスリンデターミル、インスリンデグルデック、長時間作用性動物インスリン等、用途別セグメントは、家庭用、医療機関、その他等に区分しました。長時間作用性インスリンの世界市場概観、企業動向、企業別長時間作用性インスリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・長時間作用性インスリンの市場概観 ・長時間作用性インスリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・長時間作用性インスリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・長時間作用性インスリンの世界市場規模 ・長時間作用性インスリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・長時間作用性インスリンのアメリカ市場規模推移 ・長時間作用性インスリンのカナダ市場規模推移 ・長時間作用性インスリンのメキシコ市場規模推移 ・長時間作用性インスリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・長時間作用性インスリンのドイツ市場規模推移 ・長時間作用性インスリンのイギリス市場規模推移 ・長時間作用性インスリンのロシア市場規模推移 ・長時間作用性インスリンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・長時間作用性インスリンの日本市場規模推移 ・長時間作用性インスリンの中国市場規模推移 ・長時間作用性インスリンの韓国市場規模推移 ・長時間作用性インスリンのインド市場規模推移 ・長時間作用性インスリンの東南アジア市場規模推移 ・長時間作用性インスリンの南米市場分析（ブラジル、アルゼンチン等） ・長時間作用性インスリンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・長時間作用性インスリンの種類別分析/販売量、売上、市場シェア（インスリングラルギン、インスリンデターミル、インスリンデグルデック、長時間作用性動物インスリン） ・長時間作用性インスリンの用途別分析/市場規模（家庭用、医療機関、その他） ・長時間作用性インスリンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・長時間作用性インスリンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
Scope of the Report:
The global Long Acting Insulins market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Long Acting Insulins.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Long Acting Insulins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Long Acting Insulins market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novo Nordisk
Sanofi
Wockhardt UK
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Market Segment by Applications, can be divided into
Home Use
Medical Institutions
Others
Table of Contents
1 Long Acting Insulins Market Overview
1.1 Product Overview and Scope of Long Acting Insulins
1.2 Classification of Long Acting Insulins by Types
1.2.1 Global Long Acting Insulins Revenue Comparison by Types (2019-2024)
1.2.2 Global Long Acting Insulins Revenue Market Share by Types in 2018
1.2.3 Insulin Glargine
1.2.4 Insulin Determir
1.2.5 Insulin Degludec
1.2.6 Long Acting Animal Insulin
1.3 Global Long Acting Insulins Market by Application
1.3.1 Global Long Acting Insulins Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Long Acting Insulins Market by Regions
1.4.1 Global Long Acting Insulins Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Long Acting Insulins Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Long Acting Insulins Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Long Acting Insulins Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Long Acting Insulins Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Long Acting Insulins Status and Prospect (2014-2024)
1.5 Global Market Size of Long Acting Insulins (2014-2024)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Long Acting Insulins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Long Acting Insulins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
2.3 Wockhardt UK
2.3.1 Business Overview
2.3.2 Long Acting Insulins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
3 Global Long Acting Insulins Market Competition, by Players
3.1 Global Long Acting Insulins Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Long Acting Insulins Players Market Share
3.2.2 Top 10 Long Acting Insulins Players Market Share
3.3 Market Competition Trend
4 Global Long Acting Insulins Market Size by Regions
4.1 Global Long Acting Insulins Revenue and Market Share by Regions
4.2 North America Long Acting Insulins Revenue and Growth Rate (2014-2019)
4.3 Europe Long Acting Insulins Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Long Acting Insulins Revenue and Growth Rate (2014-2019)
4.5 South America Long Acting Insulins Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)
5 North America Long Acting Insulins Revenue by Countries
5.1 North America Long Acting Insulins Revenue by Countries (2014-2019)
5.2 USA Long Acting Insulins Revenue and Growth Rate (2014-2019)
5.3 Canada Long Acting Insulins Revenue and Growth Rate (2014-2019)
5.4 Mexico Long Acting Insulins Revenue and Growth Rate (2014-2019)
6 Europe Long Acting Insulins Revenue by Countries
6.1 Europe Long Acting Insulins Revenue by Countries (2014-2019)
6.2 Germany Long Acting Insulins Revenue and Growth Rate (2014-2019)
6.3 UK Long Acting Insulins Revenue and Growth Rate (2014-2019)
6.4 France Long Acting Insulins Revenue and Growth Rate (2014-2019)
6.5 Russia Long Acting Insulins Revenue and Growth Rate (2014-2019)
6.6 Italy Long Acting Insulins Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Long Acting Insulins Revenue by Countries
7.1 Asia-Pacific Long Acting Insulins Revenue by Countries (2014-2019)
7.2 China Long Acting Insulins Revenue and Growth Rate (2014-2019)
7.3 Japan Long Acting Insulins Revenue and Growth Rate (2014-2019)
7.4 Korea Long Acting Insulins Revenue and Growth Rate (2014-2019)
7.5 India Long Acting Insulins Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Long Acting Insulins Revenue and Growth Rate (2014-2019)
8 South America Long Acting Insulins Revenue by Countries
8.1 South America Long Acting Insulins Revenue by Countries (2014-2019)
8.2 Brazil Long Acting Insulins Revenue and Growth Rate (2014-2019)
8.3 Argentina Long Acting Insulins Revenue and Growth Rate (2014-2019)
8.4 Colombia Long Acting Insulins Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Long Acting Insulins by Countries
9.1 Middle East and Africa Long Acting Insulins Revenue by Countries (2014-2019)
9.2 Saudi Arabia Long Acting Insulins Revenue and Growth Rate (2014-2019)
9.3 UAE Long Acting Insulins Revenue and Growth Rate (2014-2019)
9.4 Egypt Long Acting Insulins Revenue and Growth Rate (2014-2019)
9.5 Nigeria Long Acting Insulins Revenue and Growth Rate (2014-2019)
9.6 South Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)
10 Global Long Acting Insulins Market Segment by Type
10.1 Global Long Acting Insulins Revenue and Market Share by Type (2014-2019)
10.2 Global Long Acting Insulins Market Forecast by Type (2019-2024)
10.3 Insulin Glargine Revenue Growth Rate (2014-2024)
10.4 Insulin Determir Revenue Growth Rate (2014-2024)
10.5 Insulin Degludec Revenue Growth Rate (2014-2024)
10.6 Long Acting Animal Insulin Revenue Growth Rate (2014-2024)
11 Global Long Acting Insulins Market Segment by Application
11.1 Global Long Acting Insulins Revenue Market Share by Application (2014-2019)
11.2 Long Acting Insulins Market Forecast by Application (2019-2024)
11.3 Home Use Revenue Growth (2014-2019)
11.4 Medical Institutions Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Long Acting Insulins Market Size Forecast (2019-2024)
12.1 Global Long Acting Insulins Market Size Forecast (2019-2024)
12.2 Global Long Acting Insulins Market Forecast by Regions (2019-2024)
12.3 North America Long Acting Insulins Revenue Market Forecast (2019-2024)
12.4 Europe Long Acting Insulins Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Long Acting Insulins Revenue Market Forecast (2019-2024)
12.6 South America Long Acting Insulins Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Long Acting Insulins Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Long Acting Insulins Picture
Table Product Specifications of Long Acting Insulins
Table Global Long Acting Insulins and Revenue (Million USD) Market Split by Product Type
Figure Global Long Acting Insulins Revenue Market Share by Types in 2018
Figure Insulin Glargine Picture
Figure Insulin Determir Picture
Figure Insulin Degludec Picture
Figure Long Acting Animal Insulin Picture
Table Global Long Acting Insulins Revenue (Million USD) by Application (2014-2024)
Figure Long Acting Insulins Revenue Market Share by Applications in 2018
Figure Home Use Picture
Figure Medical Institutions Picture
Figure Others Picture
Table Global Market Long Acting Insulins Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Long Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Long Acting Insulins Type and Applications
Table Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Long Acting Insulins Type and Applications
Table Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt UK Basic Information, Manufacturing Base and Competitors
Table Wockhardt UK Long Acting Insulins Type and Applications
Table Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Global Long Acting Insulins Revenue (Million USD) by Players (2014-2019)
Table Global Long Acting Insulins Revenue Share by Players (2014-2019)
Figure Global Long Acting Insulins Revenue Share by Players in 2017
Figure Global Long Acting Insulins Revenue Share by Players in 2018
Figure Global Top 5 Players Long Acting Insulins Revenue Market Share in 2018
Figure Global Top 10 Players Long Acting Insulins Revenue Market Share in 2018
Figure Global Long Acting Insulins Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Long Acting Insulins Revenue (Million USD) by Regions (2014-2019)
Table Global Long Acting Insulins Revenue Market Share by Regions (2014-2019)
Figure Global Long Acting Insulins Revenue Market Share by Regions (2014-2019)
Figure Global Long Acting Insulins Revenue Market Share by Regions in 2018
Figure North America Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Europe Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure South America Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table North America Long Acting Insulins Revenue by Countries (2014-2019)
Table North America Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure North America Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure North America Long Acting Insulins Revenue Market Share by Countries in 2018
Figure USA Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Canada Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Mexico Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table Europe Long Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Figure Europe Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Europe Long Acting Insulins Revenue Market Share by Countries in 2018
Figure Germany Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure UK Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure France Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Russia Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Italy Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Long Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Long Acting Insulins Revenue Market Share by Countries in 2018
Figure China Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Japan Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Korea Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure India Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table South America Long Acting Insulins Revenue by Countries (2014-2019)
Table South America Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure South America Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure South America Long Acting Insulins Revenue Market Share by Countries in 2018
Figure Brazil Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Argentina Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Colombia Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Long Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Long Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Long Acting Insulins Revenue Market Share by Countries in 2018
Figure Saudi Arabia Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure UAE Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Egypt Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Nigeria Long Acting Insulins Revenue and Growth Rate (2014-2019)
Figure South Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)
Table Global Long Acting Insulins Revenue (Million USD) by Type (2014-2019)
Table Global Long Acting Insulins Revenue Share by Type (2014-2019)
Figure Global Long Acting Insulins Revenue Share by Type (2014-2019)
Figure Global Long Acting Insulins Revenue Share by Type in 2019
Table Global Long Acting Insulins Revenue Forecast by Type (2019-2024)
Figure Global Long Acting Insulins Market Share Forecast by Type (2019-2024)
Figure Global Insulin Glargine Revenue Growth Rate (2014-2019)
Figure Global Insulin Determir Revenue Growth Rate (2014-2019)
Figure Global Insulin Degludec Revenue Growth Rate (2014-2019)
Figure Global Long Acting Animal Insulin Revenue Growth Rate (2014-2019)
Table Global Long Acting Insulins Revenue by Application (2014-2019)
Table Global Long Acting Insulins Revenue Share by Application (2014-2019)
Figure Global Long Acting Insulins Revenue Share by Application (2014-2019)
Figure Global Long Acting Insulins Revenue Share by Application in 2019
Table Global Long Acting Insulins Revenue Forecast by Application (2019-2024)
Figure Global Long Acting Insulins Market Share Forecast by Application (2019-2024)
Figure Global Home Use Revenue Growth Rate (2014-2019)
Figure Global Medical Institutions Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Long Acting Insulins Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Long Acting Insulins Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Long Acting Insulins Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Long Acting Insulins Revenue Market Forecast (2019-2024)
Figure Europe Long Acting Insulins Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Long Acting Insulins Revenue Market Forecast (2019-2024)
Figure South America Long Acting Insulins Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Long Acting Insulins Revenue Market Forecast (2019-2024)
世界の速効型インスリン市場予測（～2024年） Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump. Scope of the Report: The global Rapid Actin…- 世界のQT延長症候群治療市場予測（～2024年） Long QT syndrome is a condition which affects repolarization of the heart after a heartbeat. This results in an increased risk of an irregular heartbeat which can result in palpitations, fainting, drowning, or sudden death. These episodes can be triggered by exercise or stress. Other associated symp…
- 世界の単動泥ポンプ市場予測（～2024年） Scope of the Report: The worldwide market for Single Acting Mud Pump is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Single Acting Mu…
- 世界の複動式泥ポンプ市場予測（～2024年） Scope of the Report: The worldwide market for Double Acting Mud Pump is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Double Acting Mu…
- 世界のインディカ米（長米）市場予測（～2024年） Rice grains were elongated or oblong shape, length 7 mm or more, less viscous, rice brittle, easily broken during processing, cross-sectional oblate, color white transparent than more, there are translucent and opaque. This report studies organic long-shaped rice market, from angles of company, regi…